Diane Shoda

Diane Shoda is an experienced executive in the pharmaceutical and biotechnology sectors, currently serving as CEO of Greyscaling LLC since February 2019 and as a Senior Advisor for LedgerDomain, an enterprise blockchain company. Previously, Diane held various roles at Pfizer for over three decades, culminating in positions such as Sr. Director/Director of Worldwide Regulatory, where regulatory strategies for top-selling medications like Lyrica were developed and executed. Diane also contributed as a Clinical/Regulatory Consultant at Unlearn.AI, providing expertise in AI-driven clinical trials, and served as a Senior Advisor at the Massachusetts Institute of Technology's Center for Biomedical Innovation. With a Bachelor of Science in Chemical Engineering from the Massachusetts Institute of Technology, Diane has a strong background in regulatory compliance, clinical operations, and process re-engineering.